American International Group’s Forte Biosciences FBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-224
Closed -$8K 3150
2022
Q1
$8K Sell
224
-16
-7% -$605 ﹤0.01% 3092
2021
Q4
$13K Sell
240
-7
-3% -$471 ﹤0.01% 3117
2021
Q3
$18K Sell
247
-6
-2% -$3.32K ﹤0.01% 3084
2021
Q2
$213 Buy
+253
New +$228K ﹤0.01% 2467
2020
Q2
Sell
-33
Closed -$15K 3124
2020
Q1
$15K Sell
33
-2
-6% -$782 ﹤0.01% 2962
2019
Q4
$7K Sell
35
-1
-3% -$227 ﹤0.01% 3070
2019
Q3
$9K Hold
36
﹤0.01% 3075
2019
Q2
$90K Buy
36
+1
+3% +$2.96K ﹤0.01% 2735
2019
Q1
$142K Buy
35
+4
+13% +$15.5K ﹤0.01% 2406
2018
Q4
$96K Sell
31
-1
-3% -$4.31K ﹤0.01% 2610
2018
Q3
$184K Buy
32
+1
+3% +$3.81K ﹤0.01% 2475
2018
Q2
$108K Buy
31
+1
+3% +$3.66K ﹤0.01% 2737
2018
Q1
$135K Sell
30
-2
-6% -$9.26K ﹤0.01% 2489
2017
Q4
$123K Buy
32
+17
+113% +$67.8K ﹤0.01% 2621
2017
Q3
$70K Buy
15
+1
+7% +$4.46K ﹤0.01% 2754
2017
Q2
$63K Buy
+14
New +$78.8K ﹤0.01% 2937

Other funds holding FBRX

American International Group's FBRX Position: Q2 2022 in Review

American International Group sold out of Forte Biosciences (FBRX) in Q2 2022, closing a stake of 224 shares — an estimated $8K sold.

American International Group first reported a position in FBRX in Q2 2017 and held it in 16 quarters. The position peaked at $184K in Q3 2018. 39 funds tracked by Wall St. Rank hold FBRX as of Q2 2022.

  • American International Group reported no remaining Forte Biosciences position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 224 Forte Biosciences shares in Q2 2022, an estimated $8K.
  • American International Group first reported a position in Forte Biosciences in Q2 2017 and held it in 16 quarters.
  • American International Group's Forte Biosciences position peaked at $184K in Q3 2018.
  • 39 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.